Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 10523857)

  • 1. RNA synthesis block by 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) triggers p53-dependent apoptosis in human colon carcinoma cells.
    te Poele RH; Okorokov AL; Joel SP
    Oncogene; 1999 Oct; 18(42):5765-72. PubMed ID: 10523857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cyclin-dependent kinase inhibitor 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole induces nongenotoxic, DNA replication-independent apoptosis of normal and leukemic cells, regardless of their p53 status.
    Turinetto V; Porcedda P; Orlando L; De Marchi M; Amoroso A; Giachino C
    BMC Cancer; 2009 Aug; 9():281. PubMed ID: 19674456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erybraedin C and bitucarpin A, two structurally related pterocarpans purified from Bituminaria bituminosa, induced apoptosis in human colon adenocarcinoma cell lines MMR- and p53-proficient and -deficient in a dose-, time-, and structure-dependent fashion.
    Maurich T; Iorio M; Chimenti D; Turchi G
    Chem Biol Interact; 2006 Feb; 159(2):104-16. PubMed ID: 16271357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53.
    Li JN; Gorospe M; Chrest FJ; Kumaravel TS; Evans MK; Han WF; Pizer ES
    Cancer Res; 2001 Feb; 61(4):1493-9. PubMed ID: 11245456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
    Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases 9 and 10 inhibit protein kinase C-potentiated, p53-mediated apoptosis.
    Meyer E; Vollmer JY; Bovey R; Stamenkovic I
    Cancer Res; 2005 May; 65(10):4261-72. PubMed ID: 15899818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of p53 knockout and topotecan treatment on gene expression profiles in human colon carcinoma cells: a pharmacogenomic study.
    Daoud SS; Munson PJ; Reinhold W; Young L; Prabhu VV; Yu Q; LaRose J; Kohn KW; Weinstein JN; Pommier Y
    Cancer Res; 2003 Jun; 63(11):2782-93. PubMed ID: 12782583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of RNA polymerase II as a trigger for the p53 response.
    Ljungman M; Zhang F; Chen F; Rainbow AJ; McKay BC
    Oncogene; 1999 Jan; 18(3):583-92. PubMed ID: 9989808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential response of p53 and p21 on HDAC inhibitor-mediated apoptosis in HCT116 colon cancer cells in vitro and in vivo.
    Zopf S; Neureiter D; Bouralexis S; Abt T; Glaser KB; Okamoto K; Ganslmayer M; Hahn EG; Herold C; Ocker M
    Int J Oncol; 2007 Dec; 31(6):1391-402. PubMed ID: 17982666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential apoptosis by gallotannin in human colon cancer cells with distinct p53 status.
    Al-Ayyoubi S; Gali-Muhtasib H
    Mol Carcinog; 2007 Mar; 46(3):176-86. PubMed ID: 17192871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line.
    Matsui TA; Sowa Y; Murata H; Takagi K; Nakanishi R; Aoki S; Yoshikawa M; Kobayashi M; Sakabe T; Kubo T; Sakai T
    Int J Oncol; 2007 Oct; 31(4):915-22. PubMed ID: 17786325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.
    Arango D; Corner GA; Wadler S; Catalano PJ; Augenlicht LH
    Cancer Res; 2001 Jun; 61(12):4910-5. PubMed ID: 11406570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive effect between NF-kappaB subunits and p53 protein for transcriptional activation of human p53 promoter.
    Benoit V; Hellin AC; Huygen S; Gielen J; Bours V; Merville MP
    Oncogene; 2000 Sep; 19(41):4787-94. PubMed ID: 11032029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells.
    Park SE; Lee SW; Hossain MA; Kim MY; Kim MN; Ahn EY; Park YC; Suh H; Kim GY; Choi YH; Kim ND
    Cancer Lett; 2008 Oct; 270(1):77-86. PubMed ID: 18554781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variolin B and its derivate deoxy-variolin B: new marine natural compounds with cyclin-dependent kinase inhibitor activity.
    Simone M; Erba E; Damia G; Vikhanskaya F; Di Francesco AM; Riccardi R; Bailly C; Cuevas C; Fernandez Sousa-Faro JM; D'Incalci M
    Eur J Cancer; 2005 Oct; 41(15):2366-77. PubMed ID: 16181779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (2Alpha,3beta)-2,3-dihydroxyolean-12-en-28-oic acid, a new natural triterpene from Olea europea, induces caspase dependent apoptosis selectively in colon adenocarcinoma cells.
    Reyes FJ; Centelles JJ; Lupiáñez JA; Cascante M
    FEBS Lett; 2006 Nov; 580(27):6302-10. PubMed ID: 17083937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of ser15 and lys382 modifications of p53 by blockage of transcription elongation.
    Ljungman M; O'Hagan HM; Paulsen MT
    Oncogene; 2001 Sep; 20(42):5964-71. PubMed ID: 11593403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J; Le HV; Massagué J
    Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R; Bedi A
    Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.
    Hemmati PG; Gillissen B; von Haefen C; Wendt J; Stärck L; Güner D; Dörken B; Daniel PT
    Oncogene; 2002 May; 21(20):3149-61. PubMed ID: 12082630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.